… of iodixanol did not lead to a high incidence of kidney function … of iodixanol and iopamidol
in patients with renal dysfunction. … only posed substantial nephrotoxic risk in patients with an …

… Patients in Iodixanol and Iopamidol groups were comparable in terms of … a potential
nephrotoxicity of modern contrast media in a population without pre-existing chronic kidney disease …

… on the Kidney Disease Improving Global … with iopamidol. On the other hand, when 11 trials
using iohexol were analyzed separately, IOCM (iodixanol) was related to lower nephrotoxicity …

… , cardiac function, and the presence of chronic kidney disease and coronary heart disease.
… It has been interpreted that the physicochemical properties and renal toxicity of iohexol may …

… Although the true risk of CI-AKI remains uncertain for patients with severe kidney disease, …
risk of further loss of residual kidney function following nephrotoxic exposure(s). Although …

… This study reported a modest reduction in AKI risk with iodixanol.[ … criteria: two patients had
end-stage renal disease (ESRD) on … [ 11 12 13 ] It was theorized that the nephrotoxic effects of …

… Chronic kidney disease (CKD) is considered the most … the nephrotoxicity of liposomal
iodinated contrast agents. … in the IPL group than in the iopamidol group of the present study. Our …

… patients suffering from end-stage renal disease, the adverse risk of ICM would manifest
in a reduction of residual renal … of contrast nephrotoxicity. Am J Roentgenol. 2008;191:376–82. …

… study with patients receiving iodixanol or iopamidol for CCTA… after angioplasty in chronic
kidney disease patients) trial, however… ) study, the nephrotoxicity of iodixanol and ioxaglate was …

… often reported with iodixanol compared with iopamidol and iopromide … , which increased to
14% in those with severe renal … with underlying renal diseases [17]. The proportion of urinary …